Stephanie L. Elkins MD

Hematology•Jackson, MS

Professor, Medicine, University of Mississippi School of Medicine

Join to View Full Profile

2500 North State StreetDepartment of Medicinedivision of HematologyJackson, MS 39216
Phone+1 601-984-5615
Fax+1 601-984-5689

Education & Training

University of Mississippi Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1994
University of Mississippi Medical CenterResidency, Internal Medicine, 1987 - 1991
University of Mississippi School of MedicineClass of 1987

Certifications & Licensure

MS State Medical License 1988 - 2025
American Board of Internal Medicine Hematology

Clinical Trials

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Start of enrollment: 2006 Aug 01
Completed
Phase 2
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2008 Dec 01
ACTIVE_NOT_RECRUITING
PHASE2
S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia Start of enrollment: 2009 Dec 10
Completed
Phase 2
S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Start of enrollment: 2010 Sep 01
Completed
Phase 2
S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2011 Jul 01
Withdrawn
Phase 2
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
ACTIVE_NOT_RECRUITING
PHASE3
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
Completed
Phase 3
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
COMPLETED
PHASE3
Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma
No longer available
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage Start of enrollment: 2019 Nov 22
RECRUITING
PHASE3
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Perspectives on the quality and utility of letters conforming to the AAIM guidelines.
Christopher Williams, Richard Alweis, Teresa Roth, Vera P. Luther, James C. Pile
Journal of Community Hospital Internal Medicine Perspectives. 2021-03-23
7 citations
An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Previously Treated Myeloma
Vincent L. Hansen, Morton Coleman, S. Elkins, Jeffrey P. Letzer, Moshe Yair Levy
Clinical Lymphoma, Myeloma & Leukemia. 2015-12-03
3 citations
Adoption of a Uniform Start Date for Internal Medicine Fellowships and Other Advanced Training: An AAIM White Paper
J. Christian Barrett, Richard Alweis, Michael Frank, Alec B. O'Connor, John F. McConville
The American Journal of Medicine. 2015-09-01

Press Mentions

Celebrating Its 30th Anniversary, BMT at UMMC Is Nationally RecognizedDecember 31st, 2022
Internship “Opens Eyes” of Students to the Disease That Racked Their FamiliesJuly 11th, 2022
Preventative COVID-19 Drug Could Help More MississippiansMarch 28th, 2022
Join now to see all

Professional Memberships

American College of Physicians - ACP
Member

Stephanie L. Elkins MD

Dr. Elkins is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.